Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-258836
Filing Date
2024-11-14
Accepted
2024-11-14 17:44:28
Documents
2
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LPBCLS II EQUITY OPPORTUNITIES, LPBCLS II INVESTCO, LP

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d909949dsc13ga.htm SC 13G/A 104225
2 EX-99.A d909949dex99a.htm EX-99.A 18919
  Complete submission text file 0001193125-24-258836.txt   124797
Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
Bain Capital Life Sciences Fund II, L.P. (Filed by) CIK: 0001773187 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Subject) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92962 | Film No.: 241464700
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)